MMP9 and cancer: Adenoviral-treated tumours displayed a florid innate immune response consisting of neutrophils and macrophages and the anti-cancer effect of MMP-9 delivery was abolished by therapeutic ablation of neutrophils [97], indicating that the immune influx dependent upon MMP-9 activity is responsible for delaying tumour progression.